Garry E Menzel

CIK 1556064 · President and CEO · last filed 2025-06-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$90.7K

Companies

6

Total Filings

35

Lifetime Open-Market Net

-$145.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BDTX Director 51,825 $1.75 $90.7K $0 7 2025-06-12
STOK Director $29.82 $0 6 2025-06-04
Adaptimmune Therapeutics PLC (ADAP) Delisted Director 275,703 $0.06 $16.0K -$43.4K 5 2024-07-01
TCR2 THERAPEUTICS INC. (TCRR) Delisted President and CEO 0 $1.48 $0 -$101.9K 15 2023-06-01
DVA Senior Vice President, Finance $208.66 $0 1 2013-09-11
Regulus Therapeutics Inc. (RGLS) Delisted COO & Executive VP, Finance $8.16 $0 1 2012-12-13

Recent Filings · Page 4 of 4

35 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-02-05 BDTX Conv (C) +51,825 $0 EDGAR
2019-12-20 TCR2 THERAPEUTICS INC. (TCRR) Delisted Grant (A) $0 EDGAR
2019-04-12 TCR2 THERAPEUTICS INC. (TCRR) Delisted Grant (A) $0 EDGAR
2013-09-11 DVA Grant (A) $0 EDGAR
2012-12-13 Regulus Therapeutics Inc. (RGLS) Delisted Grant (A) $0 EDGAR
Showing 3135 of 35
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.